Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Isabelle Mollet, Tech., Philippe Moskovtchenko, Tech., Xavier Thomas, Fiorenza Barraco, MD, Valérie Mialou, Tech., Valérie Dubois, MD, Franck E. Nicolini, MD PhD

Blood (2015) 126 (23): 2577.

https://doi.org/10.1182/blood.V126.23.2577.2577

Published: 2015

Journal Articles

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

Florence Beckerich, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Adriana Plesa, MD, Valerie Dubois, MD, Isabelle Mollet, Helene Labussiere, MD, Lila Gilis, MD, Sophie Ducastelle, MD, Oriane Le Borgne, CRA, Jeremy Monfray, CRA, Fiorenza Barraco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2013) 122 (21): 4639.

https://doi.org/10.1182/blood.V122.21.4639.4639

Published: 2013

Journal Articles

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Valéerie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 604.

https://doi.org/10.1182/blood.V120.21.604.604

Published: 2012

Journal Articles

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Valérie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4180.

https://doi.org/10.1182/blood.V120.21.4180.4180

Published: 2012

Journal Articles

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Franck E. Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Jihane Fattoum, MD, PhD, Isabelle Mollet, Valerie Dubois, MD

Blood (2011) 118 (21): 3111.

https://doi.org/10.1182/blood.V118.21.3111.3111

Published: 2011

Journal Articles

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Adriana Plesa, MD, Quoc-Hung Le, MD, Daniela Revesz, MD, Xavier Thomas, MD PhD, Sophie Ducastelle, MD, Franck E. Nicolini, MD PhD, Anne-Sophie Michallet, MD, Isabelle Mollet, Valerie Dubois, PhD, Melisa Clark, Charles Dumontet, MD PhD, Nicole Raus, Mauricette Michallet, MD PhD

Blood (2007) 110 (11): 5048.

https://doi.org/10.1182/blood.V110.11.5048.5048

Published: 2007

Journal Articles

Impact of Chimerism and Other Transplant Variables on Allogeneic Transplant Outcome after Reduced Intensity Conditioning (RIC) Regimens.

Veronica Ortiz Corbella, MD, Quoc-Hung Lê, MD, Franck E. Nicolini, MD, PhD, Anne Thiébaut, MD, Xavier Thomas, MD, PhD, Youcef Chelgoum, MD, Sophie Ducastelle, MD, Isabelle Mollet, PhD, Valérie Dubois, MD, Mauricette Michallet, MD, PhD

Blood (2006) 108 (11): 5258.

https://doi.org/10.1182/blood.V108.11.5258.5258

Published: 2006

NARROW

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Impact of Chimerism and Other Transplant Variables on Allogeneic Transplant Outcome after Reduced Intensity Conditioning (RIC) Regimens.

Email alerts

ASH Publications

American Society of Hematology

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Impact of Chimerism and Other Transplant Variables on Allogeneic Transplant Outcome after Reduced Intensity Conditioning (RIC) Regimens.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only